Aligos Therapeutics, Inc. (ALGS)
NASDAQ·Healthcare·Biotechnology
$6.31
-1.87%
Mkt Cap $43.23M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $440.00K | $169.00K | -61.59% | -$2.49 | -$1.91 | +23.19% | — | — |
| Q4 2025 Nov 6, 2025 | $266.67K | $741.00K | +177.87% | -$2.09 | -$3.04 | -45.45% | — | — |
| Q3 2025 Aug 6, 2025 | $433.33K | $965.00K | +122.69% | -$2.35 | -$1.53 | +34.89% | — | — |
| Q2 2025 May 6, 2025 | $500.00K | $311.00K | -37.80% | -$2.80 | -$2.11 | +24.64% | — | — |
| Q1 2025 Mar 10, 2025 | $500.00K | $629.00K | +25.80% | -$2.63 | -$3.41 | -29.66% | — | — |
| Q4 2024 Nov 6, 2024 | $433.33K | $1.27M | +192.85% | -$2.15 | -$3.07 | -42.79% | — | — |
| Q3 2024 Aug 6, 2024 | — | $1.06M | — | -$4.00 | $0.75 | +118.75% | — | — |
| Q2 2024 May 7, 2024 | — | $986.00K | — | -$4.75 | -$5.50 | -15.79% | — | — |
| Q1 2024 Mar 12, 2024 | $1.60M | $2.68M | +67.56% | -$6.75 | -$5.50 | +18.52% | — | — |
| Q4 2023 Nov 2, 2023 | $1.60M | $3.24M | +102.44% | -$12.00 | -$10.25 | +14.58% | — | — |
| Q3 2023 Aug 3, 2023 | — | $6.89M | — | -$12.50 | -$10.75 | +14.00% | — | — |
| Q2 2023 May 4, 2023 | $1.42M | $2.72M | +91.76% | -$12.25 | -$13.25 | -8.16% | — | — |
| Q1 2023 Mar 9, 2023 | $1.72M | $3.54M | +105.64% | -$12.25 | -$12.75 | -4.08% | — | — |
| Q4 2022 Nov 2, 2022 | $750.00K | $4.11M | +447.47% | -$14.25 | -$11.00 | +22.81% | — | — |
| Q3 2022 Aug 4, 2022 | — | $3.69M | — | -$16.25 | -$11.75 | +27.69% | — | — |
| Q2 2022 May 4, 2022 | $2.18M | $2.57M | +17.74% | -$16.50 | -$21.00 | -27.27% | — | — |
| Q1 2022 Mar 10, 2022 | — | $367.00K | — | -$20.75 | -$22.25 | -7.23% | — | — |
| Q4 2021 Nov 4, 2021 | $1.63M | $1.54M | -5.68% | -$20.75 | -$19.50 | +6.02% | — | — |
| Q3 2021 Aug 5, 2021 | $1.54M | $1.54M | +0.00% | -$20.25 | -$19.75 | +2.47% | — | — |
| Q2 2021 May 10, 2021 | $1.07M | $910.00K | -15.09% | -$22.50 | -$18.50 | +17.78% | — | — |